Ex Parte CORNELL et al - Page 4



                       Appeal No.  2001-0059                                                                         Page 4           
                       Application No. 08/530,370                                                                                     
               modified, however, would not have made the modification obvious unless the prior art                                   
               suggested the desirability of the modification.  In re Gordon, 733 F.2d 900, 902, 221                                  
               USPQ 1125, 1127 (Fed. Cir. 1984).  Here, we find no reason stemming from the prior                                     
               art relied on by the examiner which would have led a person having ordinary skill in the                               
               art to the claimed invention.  Miyazaki is cited in the rejection of dependent claim 11 for                            
               its description of a fluorescence-based immunoassay, but does nothing to cure the                                      
               underlying deficiencies of Cornell II=s teachings.  In our judgment, the only reason or                                
               suggestion to modify Cornell II in the manner proposed by the examiner comes from                                      
               appellants= specification.                                                                                             
                      Finally, we know of no basis for the examiner=s requirement that appellants                                    
               establish that Athe only intent of the inventors of [Cornell II] was to alter the overall                              
               amount of antibody and not the individual antibody amounts.@  Answer, page 10.                                         
                       On this record, we are constrained to reverse both of the examiner=s rejections of                             
               the claims under 35 U.S.C. ' 103.                                                                                      
               Double Patenting                                                                                                       
                       Claims 1-7 and 9 stand rejected under the doctrine of obviousness-type double                                  
               patenting as unpatentable over claims 1-25 of Cornell I (U.S. Patent No. 5,443,955).                                   
               The patented claims are directed to analytical membranes that meet all of the                                          
               limitations of claim 1 on appeal except for the specified ratio.  Again, the examiner                                  
               concluded that one skilled in the art would have been Amotivat[ed] to optimize the ratio                               
               of first receptor molecules to second receptor molecules@ in the manner required by the                                
               claims on appeal because Cornell I teaches (at column 9, lines 1-3) that Athe density of                               
               receptor molecules in the membrane can be controlled and hence optimized for the                                       
               most sensitive detection of the desired analyte.@  Answer, page 4.                                                     




Page:  Previous  1  2  3  4  5  6  Next 

Last modified: November 3, 2007